Mortality and morbidity outcomes in patients with inflammatory bowel disease with colon cancer: A nationwide analysis. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...
Colorectal Cancer Metastatic dMMR Immunotherapy (COMMIT) study: A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo (FFX/bev) in the first-line treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results